Application 076342

Type
ANDA
Sponsor
ANI PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL5MG;6.25MGNoNo
002BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL10MG;12.5MGNoNo
003BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL20MG;12.5MGNoNo
004BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL20MG;25MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
62559-414Benazepril Hydrochloride and HydrochlorothiazideBenazepril Hydrochloride and HydrochlorothiazideANI Pharmaceuticals, Inc.ANDACurrent
62559-415Benazepril Hydrochloride and HydrochlorothiazideBenazepril Hydrochloride and HydrochlorothiazideANI Pharmaceuticals, Inc.ANDACurrent
62559-416Benazepril Hydrochloride and HydrochlorothiazideBenazepril Hydrochloride and HydrochlorothiazideANI Pharmaceuticals, Inc.ANDACurrent
62559-417Benazepril Hydrochloride and HydrochlorothiazideBenazepril Hydrochloride and HydrochlorothiazideANI Pharmaceuticals, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8895ORIG2004-02-12